子宫内膜异位症与子宫肌瘤及过早死亡风险:前瞻性队列研究
结果显示,腹腔镜确诊的子宫内膜异位症与过早死亡风险升高相关(调整后HR 1.31,95%CI 1.20-1.44),主要由妇科恶性肿瘤、神经系统疾病、非恶性呼吸系统疾病及衰老/定义不明疾病死亡驱动;超声或子宫切除确诊的子宫肌瘤与全因过早死亡无关(HR 1.03,95%CI 0.95-1.11),但与妇科恶性肿瘤死亡风险升高相关(HR 2.32,95%CI 1.59-3.40)。
要点
- 腹腔镜确诊子宫内膜异位症与过早死亡风险升高相关,调整后HR为1.31(95%CI 1.20-1.44)。
- 子宫内膜异位症与妇科恶性肿瘤死亡风险升高相关(HR 2.76,95%CI 1.79-4.26)。
- 子宫肌瘤与全因过早死亡无关,但与妇科恶性肿瘤死亡风险升高相关(HR 2.32,95%CI 1.59-3.40)。
核心结论
- 有子宫内膜异位症和子宫肌瘤病史的女性可能在育龄期后仍存在过早死亡的长期风险升高。
- 子宫内膜异位症与较高的非癌症死亡风险相关,这两种疾病均与妇科癌症死亡风险升高相关。
研究设计与样本
- 通过每两年一次问卷报告腹腔镜确诊的子宫内膜异位症或超声/子宫切除确诊的子宫肌瘤,采用Cox比例风险模型估计风险比。
主要发现
- 有和无腹腔镜确诊子宫内膜异位症女性的全因过早死亡粗发病率分别为2.01/1000人年和1.40/1000人年。
- 年龄调整模型显示腹腔镜确诊子宫内膜异位症与过早死亡风险相关(HR 1.19,95%CI 1.09-1.30),进一步调整行为因素等潜在混杂后关联增强(HR 1.31,95%CI 1.20-1.44)。
- 病因别分析显示关联主要由衰老及定义不明疾病死亡(HR 1.80,95%CI 1.19-2.73)、非恶性呼吸系统疾病(HR 1.95,95%CI 1.11-3.41)、神经系统及感觉器官疾病(HR 2.50,95%CI 1.40-4.44)和妇科器官恶性肿瘤(HR 2.76,95%CI 1.79-4.26)驱动。
- 超声或子宫切除确诊的子宫肌瘤与全因过早死亡无关(HR 1.03,95%CI 0.95-1.11),但与妇科器官恶性肿瘤死亡风险升高相关(HR 2.32,95%CI 1.59-3.40)。
关键数值与推荐
- 腹腔镜确诊子宫内膜异位症与过早死亡关联的调整后HR为1.31(95%CI 1.20-1.44)。
- 子宫内膜异位症与妇科器官恶性肿瘤死亡关联的HR为2.76(95%CI 1.79-4.26)。
- 子宫肌瘤与妇科器官恶性肿瘤死亡关联的HR为2.32(95%CI 1.59-3.40)。
临床怎么用
- 基层医生在评估女性健康时应考虑子宫内膜异位症和子宫肌瘤病史,关注其长期健康风险。
- 对这两种疾病患者需重视妇科恶性肿瘤的预防和筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To prospectively assess the effect of endometriosis and uterine fibroids on the long term risk of premature mortality (younger than 70 years). DESIGN: Prospective cohort study SETTING: The Nurses' Health Study II, United States (1989-2019). PARTICIPANTS: 110 091 women aged 25-42 years in 1989 without a history of hysterectomy before endometriosis or fibroids diagnosis, cardiovascular diseases, or cancer. MAIN OUTCOME MEASURES: Hazard ratios (estimated by Cox proportional hazards models) for total and cause specific premature mortality according to laparoscopically confirmed endometriosis or ultrasound or hysterectomy confirmed uterine fibroids reported in biennial questionnaires. RESULTS: 4356 premature deaths were recorded during 2 994 354 person years of follow-up (27.2 years per person), including 1459 from cancer, 304 from cardiovascular diseases, and 90 from respiratory diseases. The crude incidence of all cause premature mortality for women with and without laparoscopically confirmed endometriosis was 2.01 and 1.40 per 1000 person years, respectively. In age adjusted models, laparoscopically confirmed endometriosis was associated with a hazard ratio of 1.19 (95% confidence interval 1.09 to 1.30) for premature death; these models were strengthened after also adjusting for potential confounders including behavioral factors (1.31, 1.20 to 1.44). Cause specific mortality analyses showed that the association was largely driven by mortality from senility and ill-defined diseases (1.80, 1.19 to 2.73), non-malignant respiratory diseases (1.95, 1.11 to 3.41), diseases of the nervous system and sense organs (2.50, 1.40 to 4.44), and malignant neoplasm of gynecological organs (2.76, 1.79 to 4.26). Ultrasound or hysterectomy confirmed uterine fibroids were not associated with all cause premature mortality (1.03, 0.95 to 1.11), but were associated with a greater risk of mortality from malignant neoplasm of gynecological organs (2.32, 1.59 to 3.40) in cause specific mortality analyses. The risk of mortality caused by cardiovascular and respiratory diseases varied according to joint categories of endometriosis and uterine fibroids, with an increased risk of all cause premature mortality among women reporting both endometriosis and uterine fibroids. CONCLUSION: Women with a history of endometriosis and uterine fibroids might have an increased long term risk of premature mortality extending beyond their reproductive lifespan. These conditions were also associated with an increased risk of death due to gynecological cancers. Endometriosis was associated with a greater risk of non-cancer mortality. These findings highlight the importance for primary care providers to consider these gynecological disorders in their assessment of women's health.
引用
- Wang YX, Farland LV, Gaskins AJ, et al. Endometriosis and uterine fibroids and risk of premature mortality: prospective cohort study. BMJ. 2024. PMID: 39567014. doi:10.1136/bmj-2023-078797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。